Posted on Sep 05, 2017
ApiFix has invented and developed a non-fusion spinal implant system for the correction of Adolescent Idiopathic Scoliosis (AIS). The implant system is inserted in a minimally invasive surgical procedure. The ApiFix system aims to improve the quality of life of patients who undergo scoliosis surgery, save hospitalization and OR time, and substantially reduce costs and recovery time associated with standard scoliosis surgery. In contrast to standard scoliosis surgery, the ApiFix system represents a game-changer in the market, with a spinal implant system, inserted in a short procedure, followed by a brief recovery period, and maintains spine flexibility.
“With our vast experience in the spine surgical field, we instantly understood the significance of the device for scoliosis patients and its market potential. We are delighted to join forces with ApiFix and exclusively distribute their products in Canada,” stated Joint Solution Alliance President, Alan Tanner.
ApiFix CEO Eran Feldhay, M.D. remarked: “We are excited to begin our penetration in the North American markets with Canadian patients. We are convinced that together with JSA we’ll succeed in delivering the ApiFix solution to more patients around the world.”
ApiFix is an innovation-driven medical device company focused on providing less invasive solutions for scoliosis patients. ApiFix’s leading product for non-fusion treatment of adolescent idiopathic scoliosis (AIS) is used today in Europe. ApiFix is led by a team of highly-regarded spine surgeons and veteran spine specialists. The company has CE clearance and is marketed in Germany, Italy, Greece, The Netherlands, Spain, Australia and Israel.
ApiFix Principals will be available to discuss the ApiFix system, clinical cases and their follow-up to potential spine surgeons from all over the world during the annual meeting of the Scoliosis Research Society, (SRS) in Philadelphia, USA on September 5-8.
ApiFix Sales & Marketing Manager,